PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.\', \'AIDS Action Baltimore, Baltimore, Maryland, USA.\', \'amfAR Institute for HIV Cure Research Community Advisory Board, USA.\', \'Delaney AIDS Research Enterprise Community Advisory Board, USA.\', \'Martin Delaney Collaboratory Community Advisory Board, USA.\', \'HIV + Aging Research Project, Palm Springs, California, USA.\', \'University of California, San Diego, AntiViral Research Center Community Advisory Board, San Diego, California, USA.\', \'Charles R. Drew University of Medicine and Science, Los Angeles, California, USA.\', \'HIV i-Base, London, United Kingdom.\', \'amfAR Institute for HIV Cure Research, San Francisco, California, USA.\', \'Center for AIDS Prevention Studies, University of California, San Francisco, San Francisco, California, USA.\', \'University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa1260
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32841311
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all